| Year |
Citation |
Score |
| 2016 |
Meyer SE, Qin T, Muench DE, Masuda K, Venkatasubramanian M, Orr E, Suarez L, Gore SD, Delwel R, Paietta E, Tallman MS, Fernandez H, Melnick A, Le Beau MM, Kogan S, et al. Dnmt3a haploinsufficiency transforms Flt3-ITD myeloproliferative disease into a rapid, spontaneous, and fully-penetrant acute myeloid leukemia. Cancer Discovery. PMID 27016502 DOI: 10.1158/2159-8290.Cd-16-0008 |
0.384 |
|
| 2015 |
Meyer SE, Orr E, Rogers AM, Doench JG, Aronow BJ, Lal A, McGlinn E, Grimes HL. Balancing Proliferation, Differentiation, and Survival: Powerful Genetic and RNAi Technologies Reveal Essential microRNA Signaling for Leukemic Progenitor Cell Fitness Blood. 126: 441-441. DOI: 10.1182/Blood.V126.23.441.441 |
0.304 |
|
| 2014 |
Velu CS, Chaubey A, Phelan JD, Meyer S, Horman SR, Wunderlich M, Guzman ML, Jegga AG, Zeleznik-Le NJ, Chen J, Mulloy JC, Cancelas JA, Jordan CT, Aronow BJ, Marcucci G, et al. Abstract 979: microRNA-mediated leukemia-initiating cell activity Cancer Research. 74: 979-979. DOI: 10.1158/1538-7445.Am2014-979 |
0.353 |
|
| 2013 |
Raines AM, Adam M, Magella B, Meyer SE, Grimes HL, Dey SK, Potter SS. Recombineering-based dissection of flanking and paralogous Hox gene functions in mouse reproductive tracts. Development (Cambridge, England). 140: 2942-52. PMID 23760953 DOI: 10.1242/Dev.092569 |
0.341 |
|
| 2012 |
Khandanpour C, Krongold J, Schütte J, Bouwman F, Vassen L, Gaudreau MC, Chen R, Calero-Nieto FJ, Diamanti E, Hannah R, Meyer SE, Grimes HL, van der Reijden BA, Jansen JH, Patel CV, et al. The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice. Blood. 120: 4006-17. PMID 22932805 DOI: 10.1182/Blood-2011-02-334722 |
0.382 |
|
| 2011 |
Khandanpour C, Krongold J, Schütte J, Bouwman F, Vassen L, Gaudreau M, Chen R, Meyer SE, Grimes HL, Van der Reijden BA, Jansen JH, Lowenberg B, Peeters JK, Chandrashekhar P, Duehrsen U, et al. The Growth Factor Independence 1 variant form GFI136N Predisposes to Acute Myeloid Leukemia by Inducing Epigenetic Changes in Oncogenes Such As Hoxa9 Blood. 118: 223-223. DOI: 10.1182/Blood.V118.21.223.223 |
0.431 |
|
| 2010 |
Meyer SE, Hasenstein JR, Baktula A, Velu CS, Xu Y, Wan H, Whitsett JA, Gilks CB, Grimes HL. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival. The American Journal of Pathology. 177: 1503-13. PMID 20639455 DOI: 10.2353/Ajpath.2010.090651 |
0.308 |
|
| 2010 |
Meyer SE, Peace BE, Bahassi el M, Kavanaugh GM, Wagh PK, Robbins SB, Yin M, Wells SI, Zinser GM, Stambrook PJ, Waltz SE. Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice. Cancer Letters. 296: 186-93. PMID 20434834 DOI: 10.1016/J.Canlet.2010.04.011 |
0.431 |
|
| 2010 |
Jiang P, Hu Q, Ito M, Meyer S, Waltz S, Khan S, Roeder RG, Zhang X. Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America. 107: 6765-70. PMID 20351249 DOI: 10.1073/Pnas.1001814107 |
0.661 |
|
| 2009 |
Meyer SE, Zinser GM, Stuart WD, Pathrose P, Waltz SE. The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis. Developmental Biology. 333: 173-85. PMID 19576199 DOI: 10.1016/J.Ydbio.2009.06.028 |
0.753 |
|
| 2009 |
Meyer SE, Waltz SE, Goss KH. The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice. Molecular Carcinogenesis. 48: 995-1004. PMID 19452510 DOI: 10.1002/mc.20551 |
0.671 |
|
| Show low-probability matches. |